市傳國泰(00293.HK)放棄「國泰港龍」品牌 公司:不就傳聞作回應
今天(8日)有消息指國泰(00293.HK)架構重組方案是將旗下國泰航空(Cathay Pacific)、國泰港龍(Cathay Dragon)及香港快運(Hong Kong Express)將會合併,並會放棄「國泰港龍」品牌,轉用「Cathay Express」。
對於相關消息,公司指不會就傳聞作出回應,並重申COVID-19疫情大流行為社會和商界帶來史無前例的嚴峻挑戰,航空公司受到的打擊尤其嚴重。由於世界各地實施的旅行限制,令商務及休閒旅行需求在一段時間內將繼續嚴重受壓。
鑑於目前形勢瞬息萬變,公司不能排除任何措施,以確保航空業務能夠渡過危機,並變得更強及更具競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.